- Report
- February 2026
- 250 Pages
Global
From €4130EUR$4,490USD£3,519GBP
- Report
- April 2026
- 160 Pages
Global
From €3054EUR$3,320USD£2,602GBP
€3817EUR$4,150USD£3,252GBP
- Report
- October 2026
- 50 Pages
Global
From €2437EUR$2,650USD£2,077GBP
- Report
- September 2026
- 192 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- September 2026
- 188 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- September 2026
- 187 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- September 2026
- 195 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- September 2026
- 184 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- August 2026
- 250 Pages
Global
From €4130EUR$4,490USD£3,519GBP
- Report
- February 2026
- 250 Pages
Global
From €4130EUR$4,490USD£3,519GBP
- Report
- February 2026
- 250 Pages
Global
From €4130EUR$4,490USD£3,519GBP
- Report
- October 2026
- 506 Pages
Global
From €5381EUR$5,850USD£4,584GBP
- Report
- October 2026
- 174 Pages
Global
From €5381EUR$5,850USD£4,584GBP
- Report
- July 2026
- 160 Pages
Global
From €7349EUR$7,990USD£6,261GBP
- Report
- July 2026
- 200 Pages
Global
From €7349EUR$7,990USD£6,261GBP
- Report
- July 2026
- 200 Pages
Global
From €7349EUR$7,990USD£6,261GBP
- Report
- August 2026
- 140 Pages
Global
From €4369EUR$4,750USD£3,722GBP
- Report
- March 2026
- 98 Pages
Global
From €3500EUR$4,076USD£3,086GBP
- Report
- February 2021
- 420 Pages
United States
From €2207EUR$2,400USD£1,881GBP
- Report
- August 2022
- 117 Pages
Global
From €4139EUR$4,500USD£3,526GBP

Venlafaxine is a medication used to treat depression, anxiety, and panic disorder. It is a serotonin-norepinephrine reuptake inhibitor (SNRI) and is classified as a Central Nervous System (CNS) drug. Venlafaxine works by increasing the levels of serotonin and norepinephrine in the brain, which helps to improve mood and reduce anxiety. It is available in both immediate-release and extended-release formulations. Common side effects include nausea, headache, insomnia, and dry mouth.
Venlafaxine is a widely prescribed medication and is available in generic form. It is marketed by several pharmaceutical companies, including Pfizer, GlaxoSmithKline, and Mylan. It is also available in combination with other medications, such as bupropion and olanzapine. Venlafaxine is available in both brand-name and generic forms, and is available in a variety of dosage forms, including tablets, capsules, and oral solutions. Show Less Read more